0%
Daily Market Update
17-Apr-20251 min readvipin kumar

Wipro guides for revenue de-growth in Q1FY26 amid tariff moves and uncertain demand- Daily Market Update 17th April 2025

Get a Smart Summary Instantly

Prompt copied

Wipro CEO Srini Pallia said that tariffs have created uncertainties for its clients, and that uncertainties have dramatically increased from FY25 to FY26. Wipro’s outlook for the first quarter of fiscal 2026 remained muted amid an uncertain macro environment, as the company guided for a degrowth of -3.5% to -1.5%.

Overview and Outlook

Global Stock Market Today

  • US equity markets settled sharply lower in range 1.7% to 3%.
  • European equity markets ended on a flat note.
  • Asian equity markets are trading mix.
  • GIFT Nifty is down by 80 points, Nifty futures likely to open around 23380 levels.

 

News highlights from across the globe

  • Asia-Pacific region are trading mix, tracking an overnight sell-off on Wall Street as US Federal Reserve Chair Jerome Powell’s speech implied a potential persistent inflation because of tariff.
  • Powell said in a speech at the Economic Club of Chicago that the central bank must ensure that tariffs do not result in persistent inflation. Fed is on wait and watch mode as far as the tariff impact is concerned.
  • Brent crude was trading 0.47% up at $66.16 a barrel.

 

Important news updates from the domestic front

  • Wipro Q4 FY25 (Consolidated, QoQ) – Revenue up 0.8% at Rs 22,504 crore versus Rs 22,319 crore. EBIT up 1% at Rs 3,902 crore versus Rs 3,863 crore. EBIT margin flat at 17.3%. Net profit up 6.6% at Rs 3,588 crore versus Rs 3,367 crore.
  • Angel One Q4 (Consolidated, YoY) – Total income down 22.1% at Rs 1,058 crore versus Rs 1,359 crore. Net Profit down 48.7% at Rs 175 crore versus Rs 340 crore. Approves and recommends final dividend of Rs 26 per share.
  • Zydus Lifesciences clarified the recent US court ruling against it regarding patent validity in the Myrbetriq case. It stated that it is assessing the order’s potential impact and confirmed that no negotiations are ongoing as the matter pertains to patent-related issues. The company attributed the stock decline to the Delaware court ruling.
  • Lupin confirmed that a US court has issued an order regarding the Myrbetriq Patent Case. Lupin clarified that it is not aware of any information that has not been disclosed to stock exchanges. The company is in the process of notifying exchanges about the court order within the required timeline. It is currently evaluating the order’s impact and will provide updates to the exchanges once the assessment is complete.
  • One 97 Communications: Vijay Shekhar Sharma, managing director and chief executive officer, announced that he has voluntarily relinquished his allotted 2.1 crore ESOPs. Consequently, a one-time acceleration of ESOP expenses amounting to Rs 492 crore will occur in the fourth quarter of fiscal 2025.
  • SBI Cards and Payment Services has partnered with Tata Digital to introduce the Tata Neu SBI Card.
  • UltraTech Cement has signed an agreement to acquire a 26% stake in Ampin C&I Power Eight Pvt. for Rs 25.5 crore, aiming to fulfill green energy requirements and optimize energy expenses.
  • DLF has signed a master framework agreement with Srijan Realty to sell IT/ITeS SEZ land in Kolkata for Rs 693 crore.
  • Deepak Nitrite: Deepak Chem Tech, a subsidiary, has issued and allotted 1.63 crore convertible redeemable preference shares with a face value of Rs 100 each to Deepak Phenolics, another wholly owned subsidiary.
  • Bharat Heavy Electricals has signed a technology transfer agreement with Bhabha Atomic Research Centre for separator applications in electrochemical cells.
  • Metropolis Healthcare announces that the acquisition of Ashok Kumar Sharma’s Scientific Pathology, initially expected to conclude within 45 days of signing the securities subscription-cum-shareholders agreement, will now require an additional 45 days to complete.

 

Nifty Overview & Outlook

Benchmark Nifty index ended higher at 23437 levels after adding 109 points to its previous closing values.

Broader markets outperformed the benchmark as Mid and Small cap indices gained 0.71% & 1.05% respectively.

Majority of sectoral indices tracked at NSE settled in green. Amongst them, PSU Bank index was at the top of the tally, gained 2.37% followed by Media, Private Banks and Oil & Gas index that rose 1.88%, 1.74% & 1.33% respectively. On the other hand, Auto, Pharma and Health Care index ended with marginal losses.

Technically, Nifty index has reached the price resistance zone of 23500-23550 spot levels. Cross and sustenance above the same will open the doors for further up move towards 23800 spot levels in near term. However, possibility of some profit taking can not be ruled out at this juncture. 23300-23280 spot zone will act as immediate supports on the down side.

 

Derivatives Overview & Outlook

Yesterday, Banknifty futures shed 2% of open interest as short covering along with some long buildup in Finnifty futures that added 8.7% of open interest and no significant changes was seen in Nifty and Midcapnifty futures on open interest front.

Majority of F&O sectors tracked at NSE settled higher. Amongst them, Capital Goods, Oil & Gas and Realty stocks witnessed maximum addition of long positions while some short buildup was seen among Auto and Pharma stocks.

On option front, call writing along with some put writing was seen at multiple strikes. Maximum positions are at 23000 PE followed by 23300 PE and 24000 CE.

 

Institutional Trading Activity

Yesterday, FIIs bought stocks worth Rs 3936 Cr in the cash segment, sold stocks futures worth Rs 1458 Cr and bought index futures worth Rs 172 Cr. DIIs were net sellers in the cash segment to the tune of Rs 2513 Cr.

 

Nifty Futures, Banknifty Futures and Finnifty Futures Key Levels

Nifty – Resistances 23520-23650; Supports 23300-23200

Banknifty – Resistances 53500-54000; Supports 52800-52500

Finnifty – Resistances 25600- 27500; Supports 25400-25300

 

F&O Security in Ban Today: BSOFT, HINDCOPPER, MANAPPURAM, NATIONALUM

 

Important Results Today: HDFCAMC, HDFCLIFE, INFY, JIOFIN, TATAELXSI

Disclosure

Globe Capital Market Limited (“GCML”) is a Stock Broker registered with BSE, NSE, MCX, NCDEX, and MSEI in all the major segments viz. Capital, F & O and CDS segments. GCML is also a Depository Participant and registered with both the Depositories viz. CDSL and NSDL. Further, GCML is a SEBI registered Portfolio Manager and Research Analyst. GCML includes subsidiaries, group and associate companies, promoters, directors, employees and affiliates.

AY Securities and Commodities Limited, Globe Derivatives and Securities Limited & Globe Fincap Limited are subsidiaries of GCML. AtoZ Finstock Private Limited, A to Z Consultants Private Limited, A to Z Venture Capital Limited, M. Agarwal Stock Brokers Private Limited, A M Share Brokers Private Limited, Shri Adinath Advertising Company Pvt. Ltd., Orient Landbase Private Limited, Bolt Synthetic Private Limited, Price ponder Private Limited, Lakshya Impex Private Limited and Launchpad Fintech Private Limited are associates of GCML.

This report has been prepared by GCML and published in accordance with the provisions of Regulation 19 of the Securities and Exchange Board of India (Research Analysts) Regulations, 2014, for use by the recipient as information only and is not for general circulation or public distribution. This report is not to be altered, transmitted, reproduced, copied, redistributed, uploaded, published or made available to others, in any form, in whole or in part, for any purpose without prior written permission from GCML. The projections and the forecasts described in this report are based on estimates and assumptions and are inherently subject to significant uncertainties and contingencies. Projections and forecasts are necessarily speculative in nature, and it can be expected that one or more of the estimates on which the projections are forecasts were based may not materialize or may vary significantly from actual results and such variations will likely increase over the period of time. This report should not be construed as an offer to sell or the solicitation of an offer to buy, purchase or subscribe to any securities, and neither this report nor anything contained therein shall form the basis of or be relied upon in connection with any contract or commitment whatsoever. It does not constitute a personal recommendation or take into account the particular investment objective, financial situation or needs of any individual in particular. The research analysts of GCML have adhered to the code of conduct under Regulation 24 (2) of the Securities and Exchange Board of India (Research Analysts) Regulations, 2014. The recipients of this report must make their own investment decisions, based on their own investment objectives, financial situation or needs and other factors. The recipients should consider and independently evaluate whether it is suitable for its/ his/ her/their particular circumstances and if necessary, seek professional / financial advice as there is substantial risk of loss. GCML does not take any responsibility thereof.

Any such recipient shall be responsible for conducting his/her/its/their own investigation and analysis of the information contained or referred to in this report and of evaluating the merits and risks involved in securities forming the subject matter of this report. The price and value of the investment referred to in this report and income from them may go up as well as down, and investors may realize profit/loss on their investments. Past performance is not a guide for future performance. Actual results may differ materially from those set forth in the projection.

This report has been prepared by GCML based on the information available in the public domain and other public sources believed to be reliable. Though utmost care has been taken to ensure its accuracy and completeness, no representation or warranty, express or implied is made by GCML that such information is accurate or complete and/or is independently verified. The contents of this report represent the assumptions and projections of GCML and GCML does not guarantee the accuracy or reliability of any projection, assurances or advice made herein. Nothing in this report constitutes investment, legal, accounting and/or tax advice or a representation that any investment or strategy is suitable or appropriate to recipients’ specific circumstances.

Since GCML or its associates are engaged in various financial activities, they might have financial interest or beneficial ownership in various companies including subject company/companies mentioned in the report. GCML or its associates have not received any compensation for investment banking or merchant banking from the subject company in the past 12 months.  GCML or its associates might have received any compensation including brokerage services and for products or services other than investment banking or merchant banking from the subject company in the past 12 months. It is confirmed that GCML or research analyst or its associates have not managed or co-managed public offering of securities for the subject company in the past 12 months.

Research analyst or GCML or its relatives’/associates’ have no material conflict of interest at the time of publication of this report. Neither research analyst nor GCML are engaged in market making activity for the subject company. It is confirmed that research analysts do not serve as an officer, director or employee of the subject company. It is also confirmed that research analyst have not received any compensation from the subject company in the past 12 months. GCML or its associates have not received any compensation or other benefits from the Subject Company or third party in connection with the research report.

No material disciplinary action has been taken on GCML by any regulatory authority impacting Equity Research Analysis activities.

The views contained in this document are those of the analyst, and the company may or may not subscribe to all the views expressed within. This information is subject to change, as per applicable law, without any prior notice. GCML reserves the right to make modifications and alternations to this statement, as may be required, from time to time.

Research analyst or GCML or its relatives’/associates’ do not have actual/beneficial ownership of 1% or more in securities of the subject company, at the end of the month immediately preceding the date of publication of the document.

Registration granted by SEBI, membership of BASL (in case of IAs) and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors.